Noula Gibson

Dr. Noula Gibson

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2020 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
NGNoula Gibson
Noula Gibson
ABAmanda M Blackmore
Amanda M Blackmore
Anne B. ChangAnne B. Chang
Anne B. Chang
MCMonica S Cooper
Monica S Cooper
AJAdam Jaffe
Adam Jaffe
AWAndrew C Wilson
Andrew C Wilson
Respiratory illness is the leading cause of mortality in children with cerebral palsy (CP). Although risk factors for developing chronic respiratory illness have been identified, comprehensive clinical care recommendations for the prevention and management of respiratory illness do not currently exist. We invited over 200 clinicians and researchers from multiple disciplines with expertise in the management of respiratory illness in children with CP to develop care recommendations using a modified Delphi method on the basis of the RAND Corporation–University of California Los Angeles Appropriateness Method. These recommendations are intended for use by the wide range of practitioners who care for individuals living with CP. They provide a framework for recognizing multifactorial primary and secondary potentially modifiable risk factors and for providing coordinated multidisciplinary care. We describe the methods used to generate the consensus recommendations, and the overall perspective on assessment, prevention, and treatment of respiratory illness in children with CP.What this paper adds: The first consensus statement for preventing and managing respiratory disease in cerebral palsy (CP). Risk factors for respiratory disease in CP should be identified early. Individuals with CP at risk of respiratory disease require regular assessment of risk factors. Effective partnerships between multidisciplinary teams, individuals with CP, and families are essential. Treatment of respiratory disease in individuals with CP must be proactive.

21 August 2017 in Disability and Rehabilitation
Verified
Journal Article
Closed access
NGNoula Gibson
Noula Gibson
ACAnnie Chappell
Annie Chappell
ABAmanda Marie Blackmore
Amanda Marie Blackmore
SMSusan Morris
Susan Morris
GWGavin Williams
Gavin Williams
GAGarry Allison
Garry Allison
Purpose: The purpose of this study is to evaluate effects of a running intervention on running ability and participation in children with cerebral palsy. Materials and method: Children with cerebral palsy (9–18 years) with Gross Motor Function Classification System levels I-III were randomly assigned to a 12-week running intervention or usual care. Primary outcomes included improvement in running ability (assessed by Goal Attainment Scaling, high level mobility (assessed by the High-Level Mobility Assessment Tool) and participation (assessed by the Participation and Environment Measure for Children and Youth). Secondary outcomes were aerobic and anaerobic fitness and agility. Blinded assessments took place at baseline and 12 weeks. Regression analysis adjusting for baseline differences was used to determine between group differences. Results: Forty-two participants (mean age 12.5 years, SD 2.8 years; 15 female) completed the study. Statistically significant group differences at 12-weeks were found for improvements in running ability (86% treatment group versus 0% control group achieved or exceeded their running goals, p < 0.001), and participation in the school environment (Participation and Environment Measure mean difference 1.18: 95%CI 1.00–1.39, p = 0.045). Conclusion: A 12-week individualized running training skills intervention results in achievement of running ability goals and participation in the school environment in children with cerebral palsy.

22 December 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
RJRowan W Johnson
Rowan W Johnson
Sian WilliamsSian Williams
Sian Williams
DGDaniel Gucciardi
Daniel Gucciardi
NBNatasha Bear
Natasha Bear
NGNoula Gibson
Noula Gibson
Objective Determine the adherence to and effectiveness of an 8-week home exercise programme for children with disabilities delivered using Physitrack, an online exercise prescription tool, compared with traditional paper-based methods. Design Single-blinded, parallel-groups, randomised controlled trial (RCT). Setting Intervention took place in participants’ homes in Western Australia. Participants Children aged 6 to 17 years, with neurodevelopmental disabilities including cerebral palsy (CP), receiving community therapy services. Intervention All participants completed an individualised home exercise programme, which was delivered to the intervention group using Physitrack and conventional paper-based methods for the control group. Primary outcome measures Adherence to exercise programme, goal achievement and exercise performance. Secondary outcome measures Enjoyment, confidence and usability of Physitrack. Results Fifty-four participants with CP (n=37) or other neurodevelopmental disabilities (n=17) were recruited. Fifty-three were randomised after one early withdrawal. Forty-six completed the 8-week programme, with 24 in the intervention group and 22 in the control group. There was no difference between the two groups for percentage of exercises completed (intervention (n=22): 62.8% (SD 27.7), control (n=22): 55.8% (SD 19.4), between group mean difference −7.0% (95% CI: −21.6 to 7.5, p=0.34)). Both groups showed significant improvement in their self-rated performance of individualised goal activities, however there was no statistically significant difference between groups for goal achievement, quality of exercise performance, enjoyment, confidence or preferred method of delivery. There were no adverse events. Conclusion Physitrack provides a therapist with a new means of providing an exercise programme with online tools such as exercise videos, but our preliminary findings indicate that it may be no better than a traditional paper-based method for improving exercise adherence or the other outcomes measured. Exercise programmes remain an intervention supported by evidence, but a larger RCT is required to fully evaluate online delivery methods. Trial registration details Australian New Zealand Clinical Trials Registry; ACTRN12616000743460.

9 August 2022 in JMIR Pediatrics and Parenting
Verified
Journal Article
Open access
RJRowan W Johnson
Rowan W Johnson
BWBecky K White
Becky K White
DGDaniel Gucciardi
Daniel Gucciardi
NGNoula Gibson
Noula Gibson
Sian WilliamsSian Williams
Sian Williams
Background: Mobile health (mHealth) apps for children are increasing in availability and scope. Therapy (physiotherapy, speech pathology, and occupational therapy) prescription apps to improve home or school program adherence work best when developed to be highly engaging for children and when they incorporate behavior change techniques (BCTs) within their design. Objective: The aim of this study was to describe the development of a user-centered therapy prescription app for children (aged 6-12 years) with neurodevelopmental disabilities (eg, cerebral palsy, autism spectrum disorder, and intellectual disability) incorporating intervention mapping (IM) and gamified design. Methods: We used an iterative, user-centered app development model incorporating the first 3 steps of IM. We conducted a needs analysis with user feedback from our previous mHealth app study, a literature review, and a market audit. Change objectives were then specified in alignment with the psychological needs of autonomy, competence, and relatedness identified in self-determination theory. From these objectives, we then selected BCTs, stipulating parameters for effectiveness and how each BCT would be operationalized. A gamification design was planned and implemented focusing on maximizing engagement in children. In total, 2 rounds of consultations with parents, teachers, and therapists and 1 round of prototype app testing with children were conducted to inform app development, with a final iteration developed for further testing. Results: The IM process resulted in the specification of app elements, self-determination theory–informed BCTs, that were embedded into the app design. The gamification design yielded the selection of a digital pet avatar with a fantasy anime visual theme and multiple layers of incentives earned by completing prescribed therapy activities. Consultation groups with professionals working with children with disabilities (4 therapists and 3 teachers) and parents of children with disabilities (n=3) provided insights into the motivation of children and the pragmatics of implementing app-delivered therapy programs that informed the app development. User testing with children with disabilities (n=4) highlighted their enthusiasm for the app and the need for support in the initial phase of learning the app. App quality testing (Mobile Application Rating Scale-user version) with the children yielded means (out of 5) of 4.5 (SD 0.8) for engagement, 3.3 (SD 1.6) for function, 3.3 (SD 1.7) for aesthetics, and 4.3 (SD 1.1) for subjective quality. Conclusions: mHealth apps designed for children can be greatly enhanced with a systematic yet flexible development process considering the specific contextual needs of the children with user-centered design, addressing the need for behavior change using the IM process, and maximizing engagement with gamification and strong visual design.

26 January 2019 in Disability and Rehabilitation
Verified
Journal Article
Closed access
Sian WilliamsSian Williams
Sian Williams
LMLottie M. McFadden
Lottie M. McFadden
ABA. M. Blackmore
A. M. Blackmore
PDPaul Davey
Paul Davey
NGNoula Gibson
Noula Gibson
Purpose: Describe physical activity energy expenditure, body composition, and nutritional intake in adolescents with cerebral palsy (CP) in the context of health recommendations. Materials and methods: A cross-sectional study of 12 adolescents, aged 12–19 years, with CP, classified as Gross Motor Function Classification System levels II–V. Actiheart® accelerometry assessed daily physical activity energy expenditure; Dual Energy X-ray Absorptiometry (DXA) and skinfold assessment measured percentage body fat; the Modified Nutrition Questionnaire for children aged 12–18 years assessed nutritional intake. Results: These adolescents spent per day a median of 413.3 min in sedentary (range: 90.0–621.9), 206.2 min in light activity (range: 48.4–509.5), and 65.5 min in moderate-vigorous physical activity (MVPA) (range: 9.4–363.9). Sixty-four percent of the participants met guidelines for time spent in MVPA, only one participant (9%) met the target for sedentary behaviour, and one (9%) participant reached all of the nutritional targets. Participants had a median percentage body fat of 43% by DXA and 40.3% by skinfold assessment. Seventy-three percent of the participants were classed as having a potentially unhealthy body composition according to percentage body fat. Conclusions: Adolescents with CP may have a high percentage body fat, and high levels of both sedentary activity and moderate-vigorous physical activity.

1 January 2007 in Disability and Rehabilitation
Verified
Journal Article
Closed access
NGNoula Gibson
Noula Gibson
HGH. Kerr Graham
H. Kerr Graham
SLSarah Love
Sarah Love
Cerebral palsy comprises a heterogenous group of neurological disorders representing a continuum of pathologies and clinical phenotypes. Although cerebral palsy is not a focal disorder, it is appropriate to treat identified focal problems as long as the intervention is goal directed. This paper reviews principles of managing muscle imbalance in the growing, changing child using a range of complementary, carefully timed intervention options. Over the past two decades these options have increasingly included intramuscular injection of botulinum toxin-A to manage focal spasticity and dystonia. The predictable movement patterns and postures characteristic of spasticity enable a systematic clinical rationale to be developed to determine the role of botulinum toxin-A to manage the spasticity and subsequently improve function. The management of dystonia with botulinum toxin-A is more complex, particularly when spasticity and dystonia are present in combination. An active therapy programme remains central to the management of movement problems in the child with cerebral palsy, including task-specific motor training, maintenance of muscle lengths, and improved muscle strength, aiming to achieve carry over improvements that persist beyond the pharmacological effects of the botulinum toxin-A. A series of case examples are presented to highlight the role of botulinum toxin-A in the overall management of the child with focal muscle hyperactivity.